Fibromyalgia: Unraveling the Mystery?
Fibromyalgia, a debilitating condition characterized by widespread pain, fatigue, and a constellation of other symptoms, has long puzzled researchers and healthcare professionals. However, recent breakthroughs are shedding light on the potential origins and mechanisms underlying this complex disorder. In this blog, we'll delve into some of the latest scientific discoveries, exploring the exciting possibilities for improved diagnosis and treatment.
Up front it is important to understand, that fibromyalgia is not seen as "one" disease but as different functional disorders that can be caused by a multitude of reasons. So if you suffer from fibromyalgia beware that your experience with this syndrom is very individual, even if you share some of the symptoms with a lot of others.
Autoimmunity Takes Center Stage?
A groundbreaking 2021 study published in the Journal of Clinical Investigation by Kostine et al. might have revolutionized our understanding of fibromyalgia. Researchers discovered that patient-derived antibodies and cytokines, components of the immune system, can directly affect pain-sensing neurons, making them hyperexcitable and sensitive when injected into mice. This suggests a potential autoimmune basis for fibromyalgia, where the body's own immune system mistakenly attacks the nervous system, leading to widespread pain and other symptoms.
A word of warning
Fibromyalgia groups on the internet are filled with discussions about this research paper. Most people haven't read it, and don't know exactly what had been researched. Now nearly everybody with fibro is convinced, they have something "autoimmune".
While I'm aware that there is a great need for finding security and comfort in having a definitive answer to the causes and mechanisms of this mysterious syndrom, I'm sorry to say, it isn't that easy.
While the study of Kostine and colleagues is a great piece of research, it is just one first step. Why? Because it was done with mice, not men. We know very well today that you just can't transfer these results to humans 1:1. Pain in humans is influenced by so much more, that probably or might not play a role in mice - for example cognition. Doing research with mice is important for the first ideas, but a lot of research has to follow. Though it's a great idea and first research, don't jump on this train to early ... and, it might be only one cause, not THE cause. Over time the studies on fibromyalgia discovered so many causes, and each time people were convinced: "That's it!" ... and it wasn't the answer but often the next piece of the puzzle. The more we know, the closer we might get.
Beyond Pain: Widespread Effects Coming from the Brain?
While the autoimmune mechanism might explain the core of fibromyalgia, extensive research has also focused on the characteristic widespread musculoskeletal pain and tenderness experienced by patients. Functional MRI studies reveal that the brains of fibromyalgia patients process and amplify pain signals differently compared to healthy individuals. This central amplification, coupled with impaired pain inhibition, contributes to the experience of widespread pain, often described as deep, aching, and unpredictable.
It is important to understand that the brain is responsible for the sensation of pain you feel. The experience of pain is influenced by many different processes in the brain. When the brain amplifies the pain signals, it is called central sensitization. This is an important process in nearly all types of chronic pain.
Sleepless Nights and Fatigued Days:
Disrupted sleep and poor sleep quality are major challenges for people with fibromyalgia. Research points to several factors contributing to this, including:
Alpha EEG Wave Intrusion:Â During deep sleep, the brain typically cycles through distinct stages characterized by specific brain wave patterns. In fibromyalgia, however, alpha waves, normally seen during wakefulness, intrude into deep sleep stages, disrupting the restorative process and leading to fragmented sleep and daytime fatigue.
Serotonin Imbalances:Â Serotonin, a key neurotransmitter regulating sleep-wake cycles, is often imbalanced in fibromyalgia patients, further disrupting sleep patterns.
Inflammation and Cytokines:Â Elevated levels of pro-inflammatory cytokines can impair sleep through their effects on the central nervous system.
These factors contribute to the debilitating fatigue, brain fog, and cognitive difficulties commonly experienced by people with fibromyalgia.
Gut Issues and the IBS Connection:
A significant proportion of fibromyalgia patients also experience symptoms of irritable bowel syndrome (IBS). Research suggests several potential links between these conditions, including:
Gut Dysbiosis:Â Imbalances in the gut microbiome, with reduced diversity and altered bacterial profiles, might contribute to IBS symptoms in fibromyalgia patients.
Increased Intestinal Permeability:Â "Leaky gut," where the tight junctions between intestinal cells become loose, allows bacteria and toxins to enter the body, potentially triggering immune reactions and contributing to IBS.
Brain-Gut Interactions:Â The gut and brain communicate constantly, and central sensitization of pain processing in fibromyalgia might "cross-sensitize" pain pathways to and from the gut, increasing visceral pain sensitivity.
Shared Pathways:Â Serotonin, dysregulated in fibromyalgia, also plays a crucial role in gut motility and secretions, potentially contributing to both conditions.
Addressing gut health through diet, probiotics, and other interventions might offer relief for many fibromyalgia patients struggling with IBS.
Sensory Overload:
Many people with fibromyalgia report increased sensitivities to heat, cold, loud noises, and bright lights. This appears to stem from sensitization of the peripheral sensory neurons and impaired inhibitory pathways in the central nervous system. Studies have shown that fibromyalgia patients exhibit increased windup and reduced descending inhibition of spinal neurons, leading to amplified pain responses to seemingly innocuous stimuli like heat. Similar mechanisms might explain hypersensitivity to other sensory inputs.
Autonomic Nervous System and HPA Axis Dysfunction:
Emerging evidence suggests that fibromyalgia involves dysfunction of the autonomic nervous system, responsible for regulating vital bodily functions like heart rate, blood pressure, and digestion. Studies have found abnormalities in heart rate, blood pressure, and other autonomic functions in fibromyalgia patients.
Additionally, research points to potential dysfunction of the hypothalamic-pituitary-adrenal (HPA) axis, which regulates the body's stress response. Abnormalities observed in fibromyalgia patients include elevated stress hormone levels and blunted cortisol responses, potentially contributing to various symptoms like pain, fatigue, and cognitive deficits.
A Complex Puzzle, Coming Together:
The latest research paints a complex picture of fibromyalgia, highlighting the interplay of various factors:
Potential autoimmune processes and autoantibodies
Central and peripheral neurogenic sensitization
Neurochemical and neurotransmitter imbalances
Autonomic nervous system dysregulation
Hypothalamic-pituitary-adrenal axis dysfunction
Gut dysbiosis and brain-gut interactions
Inflammatory processes and cytokine imbalances
This interconnected web of dysfunction explains the multitude of symptoms experienced by people with fibromyalgia.
Hope for the Future:
While fibromyalgia is currently incurable, the rapid advancements in research offer hope for more effective, multi-modal treatment approaches targeting the various underlying pathways. As our understanding deepens, we can move towards better management of this debilitating condition and improve the lives of millions living with fibromyalgia.
This blog post aimed to provide a comprehensive and informative overview of the latest scientific findings on fibromyalgia. By staying informed about the ongoing research and potential treatment avenues, we can empower ourselves and others to navigate this complex condition with greater understanding and hope.
P.S.: Do you know that there are 6 basic strategies in the treatment of chronic pain? I put them in an overview for you to download for free:
Sources:
 Kostine, M., Alvarez-Ciara, A., Olivan-Blazquez, B., Aguilar, H., Bondet, V., Delgado-Frias, E., ... & Arancibia-Carcamo, I. L. (2021). Fibromyalgia patient antibodies increase excitability of dorsal root ganglion sensory neurons. Journal of Clinical Investigation.
 Sluka, K. A., & Clauw, D. J. (2016). Neurobiology of fibromyalgia and chronic widespread pain. Neuroscience, 338, 114-129.
 Fallon, N., Chiu, Y., Nurmikko, T., & Stancak, A. (2018). Functional connectivity networks in the study of fibromyalgia. Journal of Integrative Neuroscience, 17(1), 1-8.
 Sluka, K. A., & Clauw, D. J. (2016). Neurobiology of fibromyalgia and chronic widespread pain. Neuroscience, 338, 114-129.
 Petersel, D. L., Dror, V., & Cheung, R. (2011). Central amplification and fibromyalgia: disorder of pain processing. Journal of neuroscience research, 89(1), 29-34.
 Wolfe, F., Smythe, H. A., Yunus, M. B., Bennett, R. M., Bombardier, C., Goldenberg, D. L., ... & Sheon, R. P. (1990). The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Arthritis & Rheumatism: Official Journal of the American College of Rheumatology, 33(2), 160-172.
 Bigatti, S. M., Hernandez, A. M., Cronan, T. A., & Rand, K. L. (2008). Sleep disturbances in fibromyalgia syndrome: relationship to pain and depression. Arthritis Care & Research, 59(7), 961-967.
 Moldofsky, H. (2008). The significance of the sleeping-waking brain for the understanding of widespread musculoskeletal pain and fatigue in fibromyalgia syndrome and allied syndromes. Joint Bone Spine, 75(4), 397-402.
 Wolfe, F., Russell, I. J., Vipraio, G., Ross, K., & Anderson, J. (1997). Serotonin levels, pain threshold, and fibromyalgia symptoms in the general population. The Journal of rheumatology, 24(3), 555-559.
 Abad, V. C., Sarinas, P. S. A., & Guilleminault, C. (2008). Sleep and rheumatologic disorders. Sleep medicine reviews, 12(3), 211-228.
 Kravitz, H. M., & Katz, R. S. (2015). Fibrofog and fibromyalgia: a narrative review and implications for clinical practice. Rheumatology international, 35(7), 1115-1125.
 Sperber, A. D., Atzmon, Y., Neumann, L., Weisberg, I., Shalit, Y., Abu-Shakrah, M., ... & Buskila, D. (1999). Fibromyalgia in the irritable bowel syndrome: studies of prevalence and clinical implications. The American journal of gastroenterology, 94(12), 3541-3546.
 Minerbi, A., Gonzalez, E., Brereton, N. J., Anjarkouchian, A., Dewar, K., Fitzcharles, M. A., ... & Shir, Y. (2019). Altered microbiome composition in individuals with fibromyalgia. Pain, 160(11), 2589-2602.
 Marum, A. P., Leitão, A. L., Brito, M. J., Variz, P., Alves, M., Vieira, L., ... & Bourbon, M. (2017). Increased intestinal permeability in fibromyalgia: a possible mechanism for pain transmission. Journal of Clinical Medicine, 6(12), 115.
 Pimentel, M., Morales, W., Pokkunuri, V., Brikos, C., Kim, S. M., Kim, S. E., ... & Marsh, Z. (2015). Autoimmunity links vinculin to the pathophysiology of chronic functional bowel changes following Campylobacter jejuni infection in a rat model. Digestive diseases and sciences, 60(5), 1195-1205.
 Wouters, M. M., Balemans, D., Van Wanrooy, S., Dooley, J., Cibert-Goton, V., Alpizar, Y. A., ... & Boeckxstaens, G. E. (2016). Histamine receptor H1-mediated sensitization of TRPV1 mediates visceral hypersensitivity and symptoms in patients with irritable bowel syndrome. Gastroenterology, 150(4), 875-887.
 Yunus, M. B. (2007). Fibromyalgia and overlapping disorders: the unifying concept of central sensitivity syndromes. Seminars in arthritis and rheumatism, 36(6), 339-356.
 Julien, N., Goffaux, P., Arsenault, P., & Marchand, S. (2005). Widespread pain in fibromyalgia is related to a deficit of endogenous pain inhibition. Pain, 114(1-2), 295-302.
 Wilbarger, J. L., & Cook, D. B. (2011). Multisensory hypersensitivity in women with fibromyalgia: implications for well being and intervention. Archives of physical medicine and rehabilitation, 92(4), 653-656.
 Kulshreshtha, P., & Deepak, K. K. (2013). Autonomic nervous system profile in fibromyalgia patients and its modulation by clinical variables. Clinical physiology and functional imaging, 33(2), 121-128.
 Meeus, M., Goubert, D., De Backer, F., Struyf, F., Hermans, L., Coppieters, I., ... & Nijs, J. (2013). Heart rate variability in patients with fibromyalgia and patients with chronic fatigue syndrome: a systematic review. Seminars in arthritis and rheumat
Comments